Implementation of patient and public involvement and engagement (PPIE) for the therapies for long COVID in non-hospitalised individuals (TLC) project.

Autor: Aiyegbusi OL; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk.; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk.; Applied Research Collaboration (ARC) West Midlands, National Institute for Health and Care Research (NIHR), University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK. O.L.Aiyegbusi@bham.ac.uk., McMullan C; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Applied Research Collaboration (ARC) West Midlands, National Institute for Health and Care Research (NIHR), University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK., Hughes SE; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Applied Research Collaboration (ARC) West Midlands, National Institute for Health and Care Research (NIHR), University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK., Turner GM; Sport, Exercise and Rehabilitation Science, University of Birmingham, Birmingham, UK., Haroon S; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Hotham R; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Brown K; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Alder Y; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Agyen L; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Buckland L; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Camaradou J; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Chong A; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Jeyes F; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Matthews KL; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Moore P; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Ormerod J; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Price G; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Saint-Cricq M; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Stanton D; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Walker A; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Applied Research Collaboration (ARC) West Midlands, National Institute for Health and Care Research (NIHR), University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK., Calvert MJ; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; Applied Research Collaboration (ARC) West Midlands, National Institute for Health and Care Research (NIHR), University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK.

Publikováno v: Research involvement and engagement [Res Involv Engagem] 2024 Nov 09; Vol. 10 (1), pp. 120. Date of Electronic Publication: 2024 Nov 09.

Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study).

Autor: Haroon S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK s.haroon@bham.ac.uk., Nirantharakumar K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.; Health Data Research UK (HDR UK) Midlands, Birmingham, UK., Hughes SE; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.; National Institute for Health Research (NIHR) Applied Research Centre West Midlands, Birmingham, UK., Subramanian A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Aiyegbusi OL; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.; National Institute for Health Research (NIHR) Applied Research Centre West Midlands, Birmingham, UK., Davies EH; Aparito Ltd, Wrexham, UK., Myles P; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK., Williams T; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK., Turner G; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Chandan JS; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., McMullan C; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Lord J; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Wraith DC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., McGee K; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Denniston AK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Taverner T; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Jackson LJ; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Sapey E; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Gkoutos G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Gokhale K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Leggett E; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK., Iles C; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK., Frost C; Aparito Ltd, Wrexham, UK., McNamara G; Aparito Ltd, Wrexham, UK., Bamford A; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Marshall T; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Zemedikun DT; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Price G; Patient Partners, Not applicable, UK., Marwaha S; Institute for Mental Health, University of Birmingham, Birmingham, UK., Simms-Williams N; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Brown K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Walker A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Jones K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Matthews K; Patient Partners, Not applicable, UK., Camaradou J; Patient Partners, Not applicable, UK., Saint-Cricq M; Patient Partners, Not applicable, UK., Kumar S; Patient Partners, Not applicable, UK., Alder Y; Patient Partners, Not applicable, UK., Stanton DE; Patient Partners, Not applicable, UK., Agyen L; Patient Partners, Not applicable, UK., Baber M; Patient Partners, Not applicable, UK., Blaize H; Patient Partners, Not applicable, UK., Calvert M; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.; Health Data Research UK (HDR UK) Midlands, Birmingham, UK.

Publikováno v: BMJ open [BMJ Open] 2022 Apr 26; Vol. 12 (4), pp. e060413. Date of Electronic Publication: 2022 Apr 26.

Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non-melanoma skin cancer after kidney transplantation, a pilot study.

Autor: Préterre J; CHU de Bordeaux, Service de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, Bordeaux, France., Visentin J; CHU de Bordeaux, Service d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.; Université de Bordeaux, CNRS 'ImmunoConcEpT' UMR 5164, Bordeaux, France., Saint Cricq M; Department of Nephrology, Dialysis and Organ Transplantation, Hôpital Rangueil, CHU de Toulouse, Toulouse, France., Kaminski H; CHU de Bordeaux, Service de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, Bordeaux, France.; Université de Bordeaux, CNRS 'ImmunoConcEpT' UMR 5164, Bordeaux, France., Del Bello A; Department of Nephrology, Dialysis and Organ Transplantation, Hôpital Rangueil, CHU de Toulouse, Toulouse, France.; Centre de Physiopathologie Toulouse Purpan, University Paul Sabatier, INSERM U1043, Toulouse, France., Prezelin-Reydit M; CHU de Bordeaux, Service de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, Bordeaux, France., Merville P; CHU de Bordeaux, Service de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, Bordeaux, France.; Université de Bordeaux, CNRS 'ImmunoConcEpT' UMR 5164, Bordeaux, France., Kamar N; Department of Nephrology, Dialysis and Organ Transplantation, Hôpital Rangueil, CHU de Toulouse, Toulouse, France.; Centre de Physiopathologie Toulouse Purpan, University Paul Sabatier, INSERM U1043, Toulouse, France., Couzi L; CHU de Bordeaux, Service de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, Bordeaux, France.; Université de Bordeaux, CNRS 'ImmunoConcEpT' UMR 5164, Bordeaux, France.

Publikováno v: Clinical transplantation [Clin Transplant] 2021 Mar; Vol. 35 (3), pp. e14207. Date of Electronic Publication: 2021 Jan 20.

Prévention des récidives de cancers cutanés après transplantation rénale : comparaison rétrospective de deux stratégies d’immunosuppresseurs basées sur les inhibiteurs de mTOR

Autor: Préterre, J., Visentin, J., Saint Cricq, M., Kaminski, H., Merville, P., Kamar, N., Couzi, L.

Publikováno v: In Nephrologie et Thérapeutique September 2019 15(5):392-392

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.